MexiB 6 AS A RESULT OF FORTIFICATION OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE WITH MAGNESIUM AND PYRIDOXINE: PROTEOME EFFECTS
The efficacy of ethylmethylhydroxypyridine succinate (EMHPS) depends on the concentration and activity of proteomic proteins. To provide the body with magnesium and pyridoxine is an important condition for the efficacy of EMHPS because these micronutrients are essential for maintaining neuronal fun...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2016-12-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/670 |
| Summary: | The efficacy of ethylmethylhydroxypyridine succinate (EMHPS) depends on the concentration and activity of proteomic proteins. To provide the body with magnesium and pyridoxine is an important condition for the efficacy of EMHPS because these micronutrients are essential for maintaining neuronal function.Objective: to analyze the biological effects of pyridoxineand magnesium-dependent proteins providing the molecular mechanisms of multi-targeted action of EMHPS, pyridoxine, and magnesium.Material and methods. Proteins that interact with both pyridoxine and magnesium were found in the genomic and proteomic databases. A list of 78 vitamin B6-dependent proteins, which is based on the available human genome records in NCBIPROTEIN, EMBL, UNIPROT, and HumanProteomeMap databases, was analyzed using a functional binding assay. The same assay was also applied to analyze a list 720 magnesium-dependent proteins.Results. The analysis has shown that 78 pyridoxine-dependent proteomic proteins are necessary for: 1) the synthesis and processing of amino acids; 2) cell energy metabolism (ATP synthesis), and 3) the synthesis of neurotransmitters and neuronal membranes. MexiB 6 has numerous synergistic interactions between the molecules of EMHPS, pyridoxine, and magnesium. The combination of the components of EMHPS, pyridoxine and magnesium in MexiB 6 (triple synergism) allows prediction that the drug has more pronounced clinical effects than the molecules of EMHPS, which emerges in its antihypoxic and antioxidant activities, the improvement of synaptic transmission of a signal, the neutralization of homocysteine, and the regulation of lipid and carbohydrate metabolism (restoration of cell sensitivity to insulin and carbohydrates in patients with atherosclerosis and in those at risk for diabetes mellitus or obesity). Pyridoxineand magnesium-induced potentiation of the effects of EMHPS may enhance its activity. |
|---|---|
| ISSN: | 2074-2711 2310-1342 |